Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas

BACKGROUND: Patients with pancreatic ductal adenocarcinoma (PDAC) have late diagnosis which results in poor prognosis. Currently, surgical resection is the only option for curative intent. Identifying high-risk features for patients with aggressive PDAC is essential for accurate diagnosis, prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Shreya, Bhimani, Nazim, Gill, Anthony J., Samra, Jaswinder S., Sahni, Sumit, Mittal, Anubhav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287202/
https://www.ncbi.nlm.nih.gov/pubmed/34290990
http://dx.doi.org/10.3389/fonc.2021.708963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287202/
https://www.ncbi.nlm.nih.gov/pubmed/34290990
http://dx.doi.org/10.3389/fonc.2021.708963

Ejemplares similares